May 22, 2025

The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform.

On May 22, 2025, the committee will meet in open session to discuss and make recommendations on the selection of the 2025-2026 Formula for COVID-19 vaccines for use in the United States.

  • Content current as of:

    05/22/2025

Source